Sentiment-Signal
Score-Verlauf (90 Tage)
Kritische 8-K Meldungen
| Datum | Meldung | Schwere | Filing | Auszug |
|---|---|---|---|---|
| 03.11.2025 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | ection 13(a) of the Exchange Act. ☐ Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appoin |
| 16.08.2024 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | is being filed to supplement the disclosure under Item 5.02 of the Current Report on Form 8-K filed by Medtronic plc (th |
Stammdaten
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves; and percutaneous coronary intervention products, percutaneous angioplasty balloons, and products. The company's Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure, electrosurgery products, surgical artificial intelligence and robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology and lung products, and various therapies to treat diseases, as well as products in the fields of minimally invasive gastrointestinal and hepatologic diagnostics and therapies, patient monitoring, airway management and ventilation therapies, and renal disease. Its Neuroscience Portfolio segment offers products for spinal surgeons; neurosurgeons; neurologists; pain management specialists; anesthesiologists; orthopedic surgeons; urologists; urogynecologists; interventional radiologists; ear, nose, and throat specialists; and systems that incorporate energy surgical instruments. It also provides image-guided surgery and intra-operative imaging systems and robotic guidance systems used in robot assisted spine procedures; and therapies for vasculature in and around the brain. The company's Diabetes Operating Unit segment offers insulin pumps and consumables, continuous glucose monitoring systems, smart insulin pen systems, and consumables and supplies. The company was founded in 1949 and is headquartered in Dublin, Ireland.
Unternehmen & Branche
| Name | Medtronic plc |
|---|---|
| Ticker | MDT |
| CIK | 0001613103 |
| Boerse | US |
| Sektor | Healthcare |
| Industrie | Medical - Devices |
| SIC | 3845 · Electromedical & Electrotherapeutic Apparatus |
Wertpapier & Kennzahlen
| CUSIP | 00BTN1Y11 |
|---|---|
| ISIN | US00BTN1Y113 |
| Typ | Common Stock |
| Marktkapitalisierung | 104,57 Mrd. USD |
| Beta | 0,76 |
| Dividendenrendite | 2,84 % |
Externe Quellen: SEC EDGAR » · FMP-Profil » · Yahoo Finance »
Finanzkennzahlen (SEC XBRL)
| Periode | Filing | Umsatz | Nettoergebnis | EPS | Aktiva | Eigenkapital |
|---|---|---|---|---|---|---|
| 2026-01-23 | 10-Q | 9,017,000,000 | 1,143,000,000 | 0.89 | 91,485,000,000 | 48,985,000,000 |
| 2025-10-24 | 10-Q | 8,961,000,000 | 1,374,000,000 | 1.07 | 91,346,000,000 | 48,652,000,000 |
| 2025-07-25 | 10-Q | 8,578,000,000 | 1,040,000,000 | 0.81 | 90,972,000,000 | 47,893,000,000 |
| 2025-04-25 | 10-K | 33,537,000,000 | 4,662,000,000 | 3.61 | 91,680,000,000 | 48,024,000,000 |
| 2025-01-24 | 10-Q | 8,292,000,000 | 1,294,000,000 | 1.01 | 89,973,000,000 | 49,387,000,000 |
| 2024-10-25 | 10-Q | 8,403,000,000 | 1,270,000,000 | 0.99 | 90,042,000,000 | 48,494,000,000 |
| 2024-07-26 | 10-Q | 7,915,000,000 | 1,042,000,000 | 0.80 | 89,749,000,000 | 47,947,000,000 |
| 2024-04-26 | 10-K | 32,364,000,000 | 3,676,000,000 | 2.76 | 89,981,000,000 | 50,214,000,000 |
| 2024-01-26 | 10-Q | 8,089,000,000 | 1,322,000,000 | 0.99 | 90,836,000,000 | 51,792,000,000 |
| 2023-10-27 | 10-Q | 7,984,000,000 | 909,000,000 | 0.68 | 90,087,000,000 | 51,460,000,000 |
| 2023-07-28 | 10-Q | 7,702,000,000 | 791,000,000 | 0.59 | 90,776,000,000 | 51,178,000,000 |
| 2023-04-28 | 10-K | 31,227,000,000 | 3,758,000,000 | 2.82 | 90,948,000,000 | 51,483,000,000 |
| 2023-01-27 | 10-Q | 7,727,000,000 | 1,222,000,000 | 0.92 | 94,134,000,000 | 51,441,000,000 |
| 2022-10-28 | 10-Q | 7,585,000,000 | 427,000,000 | 0.32 | 93,241,000,000 | 51,880,000,000 |
| 2022-07-29 | 10-Q | 7,371,000,000 | 929,000,000 | 0.70 | 89,914,000,000 | 52,672,000,000 |
| 2022-04-29 | 10-K | 31,686,000,000 | 5,039,000,000 | 3.73 | 90,981,000,000 | 52,551,000,000 |
| 2022-01-28 | 10-Q | 7,763,000,000 | 1,480,000,000 | 1.10 | 91,804,000,000 | 52,542,000,000 |
| 2021-10-29 | 10-Q | 7,847,000,000 | 1,311,000,000 | 0.97 | 91,756,000,000 | 51,991,000,000 |
| 2021-07-30 | 10-Q | 7,987,000,000 | 763,000,000 | 0.56 | 91,802,000,000 | 51,486,000,000 |
| 2021-04-30 | 10-K | 30,117,000,000 | 3,606,000,000 | 2.66 | 93,083,000,000 | 51,428,000,000 |
Fondsaktivität (Vorquartalsvergleich)
| Fonds | Aktuell (Stk) | Vorquartal (Stk) | Veränderung (Stk) | Wert (USD) | Status | Δ | Trend |
|---|---|---|---|---|---|---|---|
| VANGUARD GROUP INC | 128,961,343 | 0 | 128,961,343 | 12,388,026,608 | Neu | +100,0% | |
| BlackRock, Inc. | 120,537,878 | 0 | 120,537,878 | 11,578,868,646 | Neu | +100,0% | |
| STATE STREET CORP | 61,660,158 | 0 | 61,660,158 | 5,966,780,403 | Neu | +100,0% | |
| JPMORGAN CHASE & CO | 53,616,694 | 0 | 53,616,694 | 5,150,419,786 | Neu | +100,0% | |
| Capital Research Global Investors | 34,573,163 | 0 | 34,573,163 | 3,321,100,808 | Neu | +100,0% | |
| GEODE CAPITAL MANAGEMENT, LLC | 27,879,481 | 0 | 27,879,481 | 2,665,831,712 | Neu | +100,0% | |
| BANK OF AMERICA CORP /DE/ | 24,671,783 | 0 | 24,671,783 | 2,369,971,509 | Neu | +100,0% | |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 20,947,960 | 0 | 20,947,960 | 2,012,261,038 | Neu | +100,0% | |
| MORGAN STANLEY | 20,222,575 | 0 | 20,222,575 | 1,942,580,913 | Neu | +100,0% | |
| DEUTSCHE BANK AG\ | 17,748,234 | 0 | 17,748,234 | 1,704,895,358 | Neu | +100,0% | |
| NORGES BANK | 17,213,042 | 0 | 17,213,042 | 1,653,484,815 | Neu | +100,0% | |
| Invesco Ltd. | 16,232,293 | 0 | 16,232,293 | 1,559,274,057 | Neu | +100,0% | |
| ROYAL BANK OF CANADA | 14,030,830 | 0 | 14,030,830 | 1,347,800,000 | Neu | +100,0% | |
| WELLINGTON MANAGEMENT GROUP LLP | 13,359,367 | 0 | 13,359,367 | 1,283,300,796 | Neu | +100,0% | |
| FRANKLIN RESOURCES INC | 12,267,759 | 0 | 12,267,759 | 1,178,440,893 | Neu | +100,0% | |
| AMERIPRISE FINANCIAL INC | 11,995,286 | 0 | 11,995,286 | 1,152,361,490 | Neu | +100,0% | |
| NORTHERN TRUST CORP | 11,471,433 | 0 | 11,471,433 | 1,101,945,854 | Neu | +100,0% | |
| RAYMOND JAMES FINANCIAL INC | 11,253,611 | 0 | 11,253,611 | 1,081,939,906 | Neu | +100,0% | |
| Legal & General Group Plc | 10,181,883 | 0 | 10,181,883 | 978,071,684 | Neu | +100,0% | |
| First Eagle Investment Management, LLC | 9,775,234 | 0 | 9,775,234 | 939,009,000 | Neu | +100,0% | |
| ALLIANCEBERNSTEIN L.P. | 9,204,762 | 0 | 9,204,762 | 884,209,438 | Neu | +100,0% | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 8,913,417 | 0 | 8,913,417 | 856,222,836 | Neu | +100,0% | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 8,310,995 | 0 | 8,310,995 | 798,354,180 | Neu | +100,0% | |
| DIMENSIONAL FUND ADVISORS LP | 7,403,174 | 0 | 7,403,174 | 711,183,890 | Neu | +100,0% | |
| CITADEL ADVISORS LLC | 7,201,188 | 0 | 7,201,188 | 691,746,119 | Neu | +100,0% | |
| WELLS FARGO & COMPANY/MN | 7,042,167 | 0 | 7,042,167 | 676,470,609 | Neu | +100,0% | |
| Capital World Investors | 7,035,778 | 0 | 7,035,778 | 675,856,835 | Neu | +100,0% | |
| Boston Partners | 6,735,883 | 0 | 6,735,883 | 647,152,721 | Neu | +100,0% | |
| GOLDMAN SACHS GROUP INC | 6,220,848 | 0 | 6,220,848 | 597,574,706 | Neu | +100,0% | |
| STIFEL FINANCIAL CORP | 5,867,863 | 0 | 5,867,863 | 563,672,379 | Neu | +100,0% | |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | 5,350,057 | 0 | 5,350,057 | 513,999,164 | Neu | +100,0% | |
| AMERICAN CENTURY COMPANIES INC | 4,854,208 | 0 | 4,854,208 | 466,295,314 | Neu | +100,0% | |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM | 4,789,699 | 0 | 4,789,699 | 460,098,486 | Neu | +100,0% | |
| UBS Group AG | 4,641,969 | 0 | 4,641,969 | 445,907,541 | Neu | +100,0% | |
| MILLENNIUM MANAGEMENT LLC | 4,604,488 | 0 | 4,604,488 | 442,307,117 | Neu | +100,0% | |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 4,236,247 | 0 | 4,236,247 | 406,933,887 | Neu | +100,0% | |
| BARROW HANLEY MEWHINNEY & STRAUSS LLC | 4,175,858 | 0 | 4,175,858 | 401,132,919 | Neu | +100,0% | |
| BANK OF MONTREAL /CAN/ | 4,128,941 | 0 | 4,128,941 | 396,626,036 | Neu | +100,0% | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 3,819,414 | 0 | 3,819,414 | 366,892,909 | Neu | +100,0% | |
| STATE FARM MUTUAL AUTOMOBILE INSURANCE CO | 3,622,141 | 0 | 3,622,141 | 347,942,864 | Neu | +100,0% | |
| Neuberger Berman Group LLC | 3,575,048 | 0 | 3,575,048 | 343,495,670 | Neu | +100,0% | |
| Swiss National Bank | 3,514,966 | 0 | 3,514,966 | 337,647,634 | Neu | +100,0% | |
| LAZARD ASSET MANAGEMENT LLC | 3,411,802 | 0 | 3,411,802 | 327,737,666 | Neu | +100,0% | |
| BNP PARIBAS FINANCIAL MARKETS | 2,996,394 | 0 | 2,996,394 | 326,615,143 | Neu | +100,0% | |
| PZENA INVESTMENT MANAGEMENT LLC | 3,218,852 | 0 | 3,218,852 | 309,202,963 | Neu | +100,0% | |
| JANUS HENDERSON GROUP PLC | 3,114,158 | 0 | 3,114,158 | 299,162,144 | Neu | +100,0% | |
| AQR CAPITAL MANAGEMENT LLC | 3,069,104 | 0 | 3,069,104 | 294,818,100 | Neu | +100,0% | |
| National Pension Service | 2,982,411 | 0 | 2,982,411 | 286,490,401 | Neu | +100,0% | |
| Guinness Asset Management LTD | 2,857,234 | 0 | 2,857,234 | 273,966,973 | Neu | +100,0% | |
| FORT WASHINGTON INVESTMENT ADVISORS INC /OH/ | 2,605,343 | 0 | 2,605,343 | 250,269,205 | Neu | +100,0% |
Insider-Transaktionen (12 Monate)
| Datum | Insider | Rolle | Typ | Stückzahl | Kurs | Wert (USD) | Δ | Trend |
|---|---|---|---|---|---|---|---|---|
| 2026-02-19 | KIIL HARRY SKIP | Officer, EVP & President Cardiovascular | Open Market Sale | -30,568 | 97.66 | -2,985,374.81 | -505,9% | |
| 2026-02-19 | KIIL HARRY SKIP | Officer, EVP & President Cardiovascular | Open Market Sale | -668 | 97.83 | -65,347.10 | -11,1% | |
| 2026-02-19 | KIIL HARRY SKIP | Officer, EVP & President Cardiovascular | Open Market Sale | -19,255 | 97.77 | -1,882,561.35 | -319,0% | |
| 2026-02-19 | KIIL HARRY SKIP | Officer, EVP & President Cardiovascular | Open Market Sale | -1,648 | 97.86 | -161,273.28 | -27,3% | |
| 2026-02-19 | KIIL HARRY SKIP | Officer, EVP & President Cardiovascular | Open Market Sale | -385 | 97.82 | -37,660.70 | -6,4% | |
| 2025-11-19 | Smith Gregory L | Officer, EVP Global Ops & Supply Chain | Open Market Sale | -1,995 | 102.03 | -203,549.85 | -34,5% | |
| 2025-11-19 | Smith Gregory L | Officer, EVP Global Ops & Supply Chain | Open Market Sale | -24,186 | 101.93 | -2,465,278.98 | -417,8% | |
| 2025-11-19 | Smith Gregory L | Officer, EVP Global Ops & Supply Chain | Open Market Sale | -1,942 | 101.99 | -198,064.58 | -33,6% | |
| 2025-11-19 | Smith Gregory L | Officer, EVP Global Ops & Supply Chain | Open Market Sale | -227 | 102.05 | -23,165.35 | -3,9% | |
| 2025-11-19 | Smith Gregory L | Officer, EVP Global Ops & Supply Chain | Open Market Sale | -325 | 102.06 | -33,169.50 | -5,6% | |
| 2025-11-19 | Smith Gregory L | Officer, EVP Global Ops & Supply Chain | Open Market Sale | -500 | 102.08 | -51,040.00 | -8,6% | |
| 2025-11-19 | Smith Gregory L | Officer, EVP Global Ops & Supply Chain | Open Market Sale | -825 | 102.04 | -84,183.00 | -14,3% | |
| 2025-09-03 | KIIL HARRY SKIP | Officer, EVP & President Cardiovascular | Open Market Sale | -8,405 | 91.58 | -769,729.90 | -130,4% | |
| 2025-09-03 | KIIL HARRY SKIP | Officer, EVP & President Cardiovascular | Open Market Sale | -200 | 91.59 | -18,318.00 | -3,1% | |
| 2025-08-25 | Jellison William R | Director | Open Market Purchase | 2,500 | 92.37 | 230,925.00 | +39,1% | |
| 2025-08-22 | Jellison William R | Director | Open Market Purchase | 2,500 | 92.73 | 231,825.00 | +39,3% |
Top-Fondshalter
Stand: 31.03.2026
| Fonds | Anteile | Wert (USD) | Anteil (%) |
|---|---|---|---|
| OPPENHEIMER & CO INC | 197,025 | 17,072,216 | 49.09 |
| ADAMS DIVERSIFIED EQUITY FUND, INC. | 192,900 | 16,714,785 | 48.06 |
| HARTLINE INVESTMENT CORP/ | 7,225 | 626,046 | 1.80 |
| WASHINGTON CAPITAL MANAGEMENT, INC | 4,205 | 364,363 | 1.05 |